Ads
related to: mrna stock quoteinvesco.com has been visited by 100K+ users in the past month
Search results
Why Moderna (MRNA) Stock Price Was Up 13% on Tuesday
Zacks via Yahoo Finance· 5 months agoShares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to...
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Zacks via Yahoo Finance· 1 year agoModerna MRNA reported earnings of 19 cents per share for the first quarter of 2023, beating the...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 1 week agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Moderna MRNA to beat expectations when it reports first-quarter 2023 results on May 4,...
Moderna (MRNA) Issues 2023 Preliminary Results, Stock Up 4%
Zacks via Yahoo Finance· 5 months agoModerna (MRNA) reports unaudited product sales of around $6.7 billion for 2023, meeting its...
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
Zacks via Yahoo Finance· 3 months agoModerna, Inc. MRNA reported earnings of 55 cents per share in the fourth quarter of 2023, beating...
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the...
Drug, Biotech Stocks' Q4 Earnings on Feb 23: MRNA, BHC & More
Zacks via Yahoo Finance· 1 year agoAll the large drugmakers in the drug/biotech sector have already reported their fourth-quarter...
Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal
Zacks via Yahoo Finance· 2 years agoShares of Moderna MRNA were up 4.6% after management announced that the phase II/III study...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...
